Kaiser Foundation Health Plans

Health Insurance Plan

Based in DC

🤖

AI Overview

With $1.9M in lobbying spend across 32 quarterly filings, Kaiser Foundation Health Plans is a significant lobbying presence. Their lobbying covers 2 issue areas. Active from 2018 to 2025.

$1.9M
Total Spend
8
Years Active
1
Firms Hired
3
Lobbyists Deployed
2
Issues Lobbied

Spending Trend

View as table
YearLobbying Spend
2018$200K
2019$110K
2020$240K
2021$240K
2022$300K
2023$300K
2024$240K
2025$240K

Issues Lobbied

Lobbying Firms

Lobbyists

What They Lobby About

These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues, Medicare/Medicaid

Implementation of the Patient Protection and Affordable Care Act (P.L. 111-148). Legislation Amending or Repealing P.L. 111-148.

Federally-Funded Healthcare Programs and Medicare Advantage (MA)

Implementation of the Patient Protection and Affordable Care Act (P.L. 111-148). Legislation Amending or Repealing P.L. 111-148.

HR 1319, The American Rescue Plan Act; Implementation of the Patient Protection and Affordable Care Act (P.L. 111-148). Legislation Amending or Repealing P.L. 111-148.

Federally-Funded Healthcare Programs and Medicare Advantage (MA) and S. Con. Res 14 Budget Reconciliation.

HR 1319, The American Rescue Plan Act; Implementation of the Patient Protection and Affordable Care Act (P.L. 111-148). Legislation Amending or Repealing P.L. 111-148. S .Con. Res. 14 Budget Reconciliation.

Implementation of the Patient Protection and Affordable Care Act (P.L. 111-148). Legislation Amending or Repealing P.L. 111-148. S .Con. Res. 14 Budget Reconciliation.

Issues related to Medicare Advantage healthcare coverage, Medicaid, Commercial Health Insurance, and drug pricing.

Showing 8 of 14 unique descriptions from filings.

Related Analysis

Related Investigations

Explore More

Data Sources: Senate LDA Filings

Last updated: February 2026

This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.